Korea Investment Corp Alnylam Pharmaceuticals, Inc. Transaction History

Korea Investment Corp

  • $41.3 Billion
  • Q3 2024

A detailed history of Korea Investment Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Korea Investment Corp holds 107,893 shares of ALNY stock, worth $30 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
107,893
Previous 112,383 4.0%
Holding current value
$30 Million
Previous $27.3 Million 8.68%
% of portfolio
0.07%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$233.81 - $287.01 $1.05 Million - $1.29 Million
-4,490 Reduced 4.0%
107,893 $29.7 Million
Q2 2024

Aug 13, 2024
BUY
$143.31 - $247.0 $10.5 Million - $18.1 Million
73,220 Added 186.96%
112,383 $27.3 Million
Q1 2024

May 14, 2024
BUY
$146.51 - $198.2 $888,876 - $1.2 Million
6,067 Added 18.33%
39,163 $5.85 Million
Q4 2023

Feb 13, 2024
BUY
$151.41 - $196.57 $5,299 - $6,879
35 Added 0.11%
33,096 $6.33 Million
Q3 2023

Nov 13, 2023
SELL
$170.77 - $211.65 $999,687 - $1.24 Million
-5,854 Reduced 15.04%
33,061 $5.86 Million
Q2 2023

Aug 11, 2023
BUY
$185.01 - $212.05 $306,376 - $351,154
1,656 Added 4.44%
38,915 $7.39 Million
Q1 2023

May 12, 2023
BUY
$182.66 - $235.53 $203,848 - $262,851
1,116 Added 3.09%
37,259 $7.46 Million
Q4 2022

Feb 13, 2023
SELL
$185.53 - $241.31 $3.89 Million - $5.06 Million
-20,987 Reduced 36.74%
36,143 $8.59 Million
Q3 2022

Nov 10, 2022
BUY
$138.54 - $232.0 $266,135 - $445,672
1,921 Added 3.48%
57,130 $11.4 Million
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $772,373 - $1.09 Million
-6,414 Reduced 10.41%
55,209 $8.05 Million
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $183,012 - $250,256
-1,439 Reduced 2.28%
61,623 $10.1 Million
Q4 2021

Feb 09, 2022
BUY
$159.56 - $209.29 $6.34 Million - $8.32 Million
39,762 Added 170.65%
63,062 $10.7 Million
Q3 2021

Nov 12, 2021
SELL
$169.75 - $207.73 $186,725 - $228,503
-1,100 Reduced 4.51%
23,300 $4.4 Million
Q2 2021

Aug 12, 2021
SELL
$128.63 - $176.89 $25,726 - $35,378
-200 Reduced 0.81%
24,400 $4.14 Million
Q1 2021

May 13, 2021
SELL
$126.83 - $175.69 $1.03 Million - $1.42 Million
-8,100 Reduced 24.77%
24,600 $3.47 Million
Q4 2020

Feb 10, 2021
BUY
$122.97 - $147.0 $49,188 - $58,800
400 Added 1.24%
32,700 $4.25 Million
Q3 2020

Nov 12, 2020
BUY
$121.19 - $165.49 $302,975 - $413,725
2,500 Added 8.39%
32,300 $4.7 Million
Q2 2020

Aug 12, 2020
BUY
$104.21 - $156.44 $218,841 - $328,524
2,100 Added 7.58%
29,800 $4.41 Million
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $2.58 Million - $3.71 Million
27,700 New
27,700 $3.02 Million
Q3 2018

Nov 13, 2018
SELL
$87.52 - $122.67 $814,111 - $1.14 Million
-9,302 Closed
0 $0
Q1 2018

May 09, 2018
BUY
$115.92 - $148.54 $1.08 Million - $1.38 Million
9,302 New
9,302 $1.11 Million

Others Institutions Holding ALNY

# of Institutions
658
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.23M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $34.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email